GLUCARPIDASE

GLUCARPIDASE was reported 363 times

GLUCARPIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LABORATORY TEST INTERFERENCE 58 0.0738
1 LEUKAEMIC LYMPHOMA 1 0.0263
2 OSTEOSARCOMA RECURRENT 1 0.0167
3 URINE OUTPUT 1 0.0156
4 FALSE POSITIVE INVESTIGATION RESULT 15 0.0149
5 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2 0.0113
6 OSTEOSARCOMA METASTATIC 1 0.0105
7 DRUG CLEARANCE DECREASED 9 0.0069
8 ALKALOSIS 2 0.0052
9 CRYSTAL NEPHROPATHY 3 0.0051
10 CRYSTALLURIA 2 0.0037
11 GENITAL EROSION 1 0.0034
12 REBOUND EFFECT 33 0.0029
13 FRONTOTEMPORAL DEMENTIA 1 0.0023
14 HYPERVOLAEMIA 11 0.0022
15 EPIDERMAL NECROSIS 2 0.0021
16 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
17 CARDIORENAL SYNDROME 1 0.0017
18 ARACHNOIDITIS 1 0.0014
19 TOXIC LEUKOENCEPHALOPATHY 1 0.0014
20 NEPHROPATHY TOXIC 13 0.0012
21 TREATMENT DELAYED 2 0.0012
22 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
23 DRUG LEVEL FLUCTUATING 1 0.0011
24 PROTHROMBIN LEVEL DECREASED 1 0.0011
25 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
26 DRUG LEVEL INCREASED 16 0.0010
27 ASTERIXIS 1 0.0009
28 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
29 DRUG EFFECT INCOMPLETE 33 0.0009
30 MUCOSAL INFLAMMATION 23 0.0009
31 BILIRUBIN CONJUGATED INCREASED 2 0.0009
32 UNDERDOSE 62 0.0008
33 ORAL MUCOSA EROSION 1 0.0008
34 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
35 AZOTAEMIA 3 0.0008
36 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
37 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
38 RESUSCITATION 1 0.0006
39 HEPATORENAL SYNDROME 1 0.0006
40 EROSIVE OESOPHAGITIS 1 0.0006
41 HYPERTRANSAMINASAEMIA 4 0.0006
42 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
43 RADIOTHERAPY 1 0.0005
44 BLOOD CREATININE INCREASED 34 0.0005
45 FLUID OVERLOAD 7 0.0005
46 HAEMODIALYSIS 4 0.0005
47 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
48 NEUROLOGICAL DECOMPENSATION 1 0.0004
49 RASH VESICULAR 2 0.0004
50 THERAPY CHANGE 4 0.0004
51 SYSTEMIC CANDIDA 1 0.0004
52 TOXIC ENCEPHALOPATHY 2 0.0004
53 ANURIA 3 0.0003
54 INFUSION SITE REACTION 1 0.0003
55 BLOOD CULTURE POSITIVE 1 0.0003
56 ENCEPHALOPATHY 8 0.0003
57 BACTERIAL SEPSIS 1 0.0003
58 INJECTION SITE INFECTION 1 0.0003
59 PRESCRIBED UNDERDOSE 6 0.0003
60 HEPATOCELLULAR INJURY 4 0.0003
61 INTENTIONAL UNDERDOSE 2 0.0003
62 PANCYTOPENIA 15 0.0003
63 ACIDOSIS 2 0.0003
64 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
65 ACUTE KIDNEY INJURY 36 0.0002
66 URINE OUTPUT DECREASED 2 0.0002
67 NEUROTOXICITY 4 0.0002
68 BLOOD BILIRUBIN INCREASED 6 0.0002
69 DRUG EFFECT DELAYED 1 0.0002
70 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
71 RENAL FAILURE ACUTE 9 0.0002
72 PULSE ABSENT 1 0.0002
73 SUBDURAL HAEMATOMA 3 0.0002
74 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
75 TOXICITY TO VARIOUS AGENTS 34 0.0002
76 TOXIC SKIN ERUPTION 2 0.0002
77 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
78 BONE MARROW FAILURE 4 0.0002
79 THERAPY PARTIAL RESPONDER 3 0.0002
80 RENAL PAIN 2 0.0002
81 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
82 RENAL FAILURE 25 0.0002
83 STATUS EPILEPTICUS 2 0.0002
84 PROTHROMBIN TIME PROLONGED 1 0.0002
85 NO THERAPEUTIC RESPONSE 2 0.0002
86 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
87 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
88 OLIGURIA 1 0.0002
89 BRAIN OEDEMA 2 0.0002
90 RENAL IMPAIRMENT 13 0.0002
91 WALKING AID USER 1 0.0002
92 DIALYSIS 2 0.0001
93 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
94 PRODUCT SUPPLY ISSUE 1 0.0001
95 CARDIOGENIC SHOCK 2 0.0001
96 PRODUCT AVAILABILITY ISSUE 3 0.0001
97 HAEMODYNAMIC INSTABILITY 1 0.0001
98 BLOOD ALBUMIN DECREASED 1 0.0001
99 PLEURAL EFFUSION 7 0.0001
100 HYPOXIA 4 0.0001
101 DRUG ERUPTION 2 0.0001
102 MENTAL STATUS CHANGES 3 0.0001
103 OFF LABEL USE 92 0.0001
104 PRESCRIBED OVERDOSE 2 0.0001
105 RENAL TUBULAR NECROSIS 1 0.0001
106 HEPATOMEGALY 1 0.0001
107 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
108 FLUID RETENTION 5 0.0001
109 DRUG LEVEL DECREASED 1 0.0001
110 NEUTROPHIL COUNT INCREASED 1 0.0001
111 METABOLIC ACIDOSIS 3 0.0001
112 SEPTIC SHOCK 4 0.0001
113 STAPHYLOCOCCAL INFECTION 3 0.0001
114 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
115 HEPATOTOXICITY 2 0.0001
116 SKIN INFECTION 1 0.0001
117 ELECTROLYTE IMBALANCE 1 0.0001
118 HYPERKALAEMIA 3 0.0001
119 BACTERAEMIA 1 0.0001
120 ATAXIA 1 0.0001
121 CYTOPENIA 1 0.0001
122 RESPIRATORY DEPRESSION 1 0.0001
123 LIVER INJURY 2 0.0001
124 NEUTROPENIA 11 0.0001
125 GENERALISED OEDEMA 1 0.0001
126 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
127 DYSARTHRIA 3 0.0001
128 UNRESPONSIVE TO STIMULI 2 0.0001
129 NO ADVERSE EVENT 14 0.0001
130 BEDRIDDEN 1 0.0001
131 OEDEMA 4 0.0001
132 RESPIRATORY ARREST 2 0.0001
133 RESPIRATORY DISTRESS 2 0.0001
134 THROMBOCYTOPENIA 8 0.0001
135 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
136 ASCITES 2 0.0001
137 LIVER DISORDER 3 0.0001
138 PULMONARY OEDEMA 3 0.0001
139 HEPATIC FAILURE 2 0.0001
140 BLOOD COUNT ABNORMAL 1 0.0001
141 DRUG-INDUCED LIVER INJURY 2 0.0001
142 RASH ERYTHEMATOUS 3 0.0001
143 VENTRICULAR TACHYCARDIA 1 0.0001
144 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
145 BLOOD UREA INCREASED 1 0.0001
146 DISEASE PROGRESSION 7 0.0001
147 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
148 DRUG INTERACTION 9 0.0001
149 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
150 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
151 CEREBRAL HAEMORRHAGE 2 0.0001
152 DRUG EFFECT DECREASED 3 0.0001
153 MYELOSUPPRESSION 2 0.0001
154 HEPATIC STEATOSIS 1 0.0001
155 HEPATIC FUNCTION ABNORMAL 2 0.0001
156 PRODUCT ADMINISTRATION ERROR 1 0.0000
157 THERAPEUTIC RESPONSE DECREASED 3 0.0000
158 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
159 DERMATITIS 1 0.0000
160 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
161 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
162 TRANSAMINASES INCREASED 1 0.0000
163 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
164 PERICARDIAL EFFUSION 1 0.0000
165 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
166 PRODUCT PRESCRIBING ERROR 1 0.0000
167 RESPIRATORY FAILURE 3 0.0000
168 AGITATION 3 0.0000
169 OSTEONECROSIS OF JAW 1 0.0000
170 SKIN LESION 1 0.0000
171 ANAPHYLACTIC REACTION 2 0.0000
172 SEPSIS 4 0.0000
173 DEMENTIA 1 0.0000
174 SEIZURE 4 0.0000
175 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
176 PSYCHOTIC DISORDER 1 0.0000
177 CORONARY ARTERY DISEASE 1 0.0000
178 DEATH 27 0.0000
179 URINARY RETENTION 1 0.0000
180 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
181 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
182 HYPOTENSION 5 0.0000
183 EXTRA DOSE ADMINISTERED 1 0.0000
184 NEUTROPHIL COUNT DECREASED 1 0.0000
185 CARDIO-RESPIRATORY ARREST 1 0.0000
186 DRUG INEFFECTIVE 31 0.0000
187 RECTAL HAEMORRHAGE 1 0.0000
188 OVERDOSE 5 0.0000
189 CONDITION AGGRAVATED 7 0.0000
190 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
191 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
192 HYPOKALAEMIA 1 0.0000
193 ABDOMINAL PAIN 5 0.0000
194 RENAL DISORDER 1 0.0000
195 ARRHYTHMIA 1 0.0000
196 DYSPHAGIA 2 0.0000
197 ANAEMIA 4 0.0000
198 AGGRESSION 1 0.0000
199 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
200 CONFUSIONAL STATE 3 0.0000
201 MEDICATION ERROR 1 0.0000
202 NECK PAIN 1 0.0000
203 OXYGEN SATURATION DECREASED 1 0.0000
204 INCORRECT DOSE ADMINISTERED 4 0.0000
205 HERPES ZOSTER 1 0.0000
206 LOSS OF CONSCIOUSNESS 2 0.0000
207 DEEP VEIN THROMBOSIS 1 0.0000
208 AMNESIA 1 0.0000
209 INFUSION RELATED REACTION 1 0.0000
210 FEBRILE NEUTROPENIA 1 0.0000
211 PRODUCT QUALITY ISSUE 2 0.0000
212 HYPERTENSION 3 0.0000
213 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
214 DIABETES MELLITUS 1 0.0000
215 HOSPITALISATION 2 0.0000
216 CARDIAC FAILURE 1 0.0000
217 THROMBOSIS 1 0.0000
218 PNEUMONIA 4 0.0000
219 CARDIAC ARREST 1 0.0000
220 SKIN EXFOLIATION 1 0.0000
221 CEREBROVASCULAR ACCIDENT 2 0.0000
222 INTENTIONAL PRODUCT MISUSE 1 0.0000
223 TACHYCARDIA 1 0.0000
224 HYPERSENSITIVITY 2 0.0000
225 PULMONARY EMBOLISM 1 0.0000
226 ATRIAL FIBRILLATION 1 0.0000
227 WEIGHT INCREASED 2 0.0000
228 PYREXIA 3 0.0000
229 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
230 OEDEMA PERIPHERAL 1 0.0000
231 DYSPNOEA 4 0.0000
232 VOMITING 3 0.0000
233 URINARY TRACT INFECTION 1 0.0000
234 GAIT DISTURBANCE 1 0.0000
235 MALAISE 2 0.0000
236 COUGH 1 0.0000
237 RASH 1 0.0000
238 HEADACHE 1 0.0000
239 FATIGUE 1 0.0000
240 NAUSEA 1 0.0000